SEC Form 4 · accession 0001600132-16-000108
Bellerophon Therapeutics, Inc. · BLPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin Dekker
Officer — VP of Device Engineering
Period of report
Sep 12, 2016
Accepted (ET)
Sep 13, 2016 · 8:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001600132
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 12, 2016 | F | 13,333 | $1.38 | D | 23,181 | D |
Table II — derivative securities
No Table II lines on this filing.